Abstract
Numerous nucleic acid amplification assays utilizing different target genes of the SARS-CoV-2 genome have received emergency use authorization (EUA) by the United States Food and Drug Administration (FDA). Limited data are available comparing the test performance characteristics of these assays.
Author supplied keywords
Cite
CITATION STYLE
APA
Stevens, B., Hogan, C. A., Sahoo, M. K., Huang, C. H., Garamani, N., Zehnder, J., … Pinsky, B. A. (2020). Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA. Journal of Applied Laboratory Medicine, 5(6), 1307–1312. https://doi.org/10.1093/jalm/jfaa135
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free